Fibulin 1 and Gastric Cancer
Author Information
Author(s): Cheng Y Y, Jin H, Liu X, Siu J M T, Wong Y P, Ng E K O, Yu J, Leung W-k, Sung J J Y, Chan F K L
Primary Institution: The Chinese University of Hong Kong
Hypothesis
Is fibulin 1 (FBLN1) a tumor suppressor gene that is epigenetically silenced in gastric cancer?
Conclusion
FBLN1 is identified as a novel candidate tumor suppressor gene that is downregulated through promoter hypermethylation in gastric cancer.
Supporting Evidence
- FBLN1 expression was downregulated in 84% of primary gastric carcinoma tissues.
- Hypermethylation of the FBLN1 promoter was detected in 71% of gastric cancer cell lines.
- Ectopic expression of FBLN1 inhibited the growth of gastric cancer cells.
Takeaway
Fibulin 1 is a gene that helps prevent cancer, and in stomach cancer, it often gets turned off due to a chemical change in its DNA.
Methodology
The study involved analyzing gastric cancer cell lines and primary tissues for FBLN1 expression and promoter methylation using quantitative real-time PCR and methylation-specific PCR.
Limitations
The study could not find significant associations between FBLN1 methylation and clinical characteristics, possibly due to limited resolution of methylation analysis.
Participant Demographics
The study included 102 gastric adenocarcinoma tissues and 10 normal gastric specimens.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website